Friday, September 13, 2024

Healthcare

Eli Lilly obesity drug approval in China strengthens market position amid GLP-1 agonist competition: GlobalData

GlobalData, a data and analytics company, on Friday said that tirzepatide is the first dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor...